NEW YORK (TheStreet) -- RATINGS CHANGES
Air Lease (AL) was upgraded to hold at TheStreet Ratings.
Allergan (AGN) was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $190. Value in a potential transaction with Valeant, J.P. Morgan said.
Must Read: Analysts' Actions: AGN FB HD NDAQ UA
AO Smith was upgraded at Wedbush to outperform from neutral. Twelve-month price target is $53. Growth outlook remains encouraging, Wedbush said.
AO Smith was upgraded at BMO Capital to outperform from market perform. Twelve-month price target is $57. China should continue to drive the company's growth, BMO Capital said.
AthenaHealth (ATHN) was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $192. See growth potential in both the core ambulatory business and expansion into the inpatient market, Morgan Stanley said.
Brown & Brown (BRO) was downgraded at Compass Point BRO was downgraded from Buy to Neutral, Compass Point said. $33 price target. Company could face near-term margin pressure.
Cabot (COG) was upgraded at Societe Generale to buy. Twelve-month price target is $43. Stock has lagged year-to-date, but fundamentals remain attractive, Societe Generale said.
Equifax (EFX) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $80. Organic revenue growth should accelerate, Credit Suisse said.